Kiora Pharmaceuticals Inc
KPRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001372514
No open-market purchases or sales by Kiora Pharmaceuticals Inc insiders were filed in the last 90 days; 22 institutions reported holding it in 13F filings for Q2 2026, worth $2.91M in total; no superinvestor holds it.
Other share classesKPHMW
Q4 2023 vs. Q3 2023
How the institutions holding Kiora Pharmaceuticals Inc changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 14 | 15 | +1 |
| Shares | 160.1K | 302.7K | +142.7K (+89.1%) |
| Value | $91.9K | $159.5K | +$67.6K (+73.5%) |
New holders (3)
Institutions that held Kiora Pharmaceuticals Inc at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 92,585 | $49.1K | 0.00% |
| Virtu Financial LLC | 28,441 | $15.0K | 0.00% |
| Renaissance Technologies LLC | 18,700 | $10.0K | 0.00% |
Sold out (2)
Institutions that held Kiora Pharmaceuticals Inc at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| XTX Topco Ltd | 11,790 | $6.94K |
| FMR LLC | 2 | $1 |